EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Online decision aid for patients with prostate cancer evaluated by 11 290 patients and 91 urologists in Germany

Johannes Huber, Philipp Karschuck, Johanna Valdix, Christian Thomas, Rainer Koch, Andreas Ihrig, Tobias Hölscher, Tanja Krones, Elke Kessler, Sabine Kliesch, Clemens Linné, Paul Enders und 3 weitere

BJU International · 2024-08 · 134 (2) · 239-248

DOI: 10.1111/bju.16329 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BJU International, online erschienen am 20.03.2024. Verfasst von Johannes Huber und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Philipps University of Marburg, Marburg, Germany. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Urologists, Decision Support Techniques. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Takeda Pharma Vertrieb GmbH & Co KG, Janssen-Cilag GmbH, Apogepha Arzneimittel GmbH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To evaluate the nationwide online decision aid ‘Entscheidungshilfe Prostatakrebs’ (established in 2016, >11.000 users and 60 new users/week) for patients with non‐metastatic prostate cancer (PCa), from the perspective of patients and urologists. Patients and Methods To provide personalised information, the tool collects most of the International Consortium for Health Outcomes Measurement standard set, personal preferences, psychological features, and a validated rating of the tool. To evaluate urologists’ opinions, we developed a structured two‐page questionnaire. All data were collected anonymously.

Results

From June 2016 to December 2020, 11 290 patients used the PCa decision aid. Their median (interquartile range [IQR]) age was 67 (61–72) years. The median (IQR) time from initial diagnosis to using the tool was 4 (3–7) weeks. In all, 87.7% of users reported high satisfaction. In a multivariable model, predictors for considering observation were higher knowledge, using the decision aid alone, lower oncological risk, normal erectile function, and respective personal preferences. Of 194 urologists, 91 (47%) had implemented the decision aid in their clinical practice. The urologists’ mean (SD) satisfaction score (1 ‘very good’; 6 ‘unsatisfactory’) with it was 1.45 (0.55), and 92% recommended it. Half of the urologists reported time savings.

Conclusion

Patients and urologists report a very high level of acceptance and satisfaction with this online tool. It offers advantages in shared decision‐making and time efficiency. The usage of the decision aid might improve the adoption of active surveillance and watchful waiting when indicated.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsUrologistsDecision Support TechniquesHumansMaleAgedMiddle AgedGermanySurveys and QuestionnairesPatient SatisfactionInternet

Stichwörter der Autor:innen

decision aiddecision makinghealth services researchprostate cancershared decision‐making

Autor:innen und Institutionen

  • Department of Urology, Philipps University of Marburg, Marburg, Germany.
  • Department of Urology, Medical Faculty Carl Gustav Carus, TU Dresden, Dresden, Germany.
  • Division of Psycho-Oncology, Department of General Internal Medicine and Psychosomatic, University Hospital Heidelberg, Heidelberg, Germany.
  • Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany.
  • Institute of Biomedical Ethics and History of Medicine University of Zürich, University Hospital Zürich, Zürich, Switzerland.
  • ASD Concepts GmbH & Co. KG - Institut für Patientenzentrierte Versorgungsformen, Reinheim, Germany.

Förderung

  • Takeda Pharma Vertrieb GmbH & Co KG
  • Janssen-Cilag GmbH
  • Apogepha Arzneimittel GmbH

Zitieren

APA

Huber, J., Karschuck, P., Valdix, J., Thomas, C., Koch, R., Ihrig, A., Hölscher, T., Krones, T., Kessler, E., Kliesch, S., Linné, C., Enders, P., Michel, M. S., Wülfing, C., & Groeben, C. (2024). Online decision aid for patients with prostate cancer evaluated by 11 290 patients and 91 urologists in Germany. BJU International, 134(2), 239-248. https://doi.org/10.1111/bju.16329

Vancouver

Huber J, Karschuck P, Valdix J, Thomas C, Koch R, Ihrig A, et al. Online decision aid for patients with prostate cancer evaluated by 11 290 patients and 91 urologists in Germany. BJU International. 2024;134(2):239-248. doi:10.1111/bju.16329

BibTeX
@article{Huber2024,
  author = {Huber, Johannes and Karschuck, Philipp and Valdix, Johanna and Thomas, Christian and Koch, Rainer and Ihrig, Andreas and Hölscher, Tobias and Krones, Tanja and Kessler, Elke and Kliesch, Sabine and Linné, Clemens and Enders, Paul and Michel, Maurice-Stephan and Wülfing, Christian and Groeben, Christer},
  title = {Online decision aid for patients with prostate cancer evaluated by 11 290 patients and 91 urologists in Germany},
  journal = {BJU International},
  year = {2024},
  volume = {134},
  number = {2},
  pages = {239--248},
  doi = {10.1111/bju.16329}
}
Kostenlos starten →